NCT03947151View on ClinicalTrials.gov

Efficacy and Tolerance of an Ovarian Stimulation Protocol Combining Follicle Stimulating Hormone (FSH) and Degarelix Acetate in Female Candidates for Fertility Preservation Before Chemotherapy for Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

November 28, 2019

Primary Completion Date

March 31, 2022

Study Completion Date

August 30, 2022

Conditions
Invasive Ductal Breast Carcinoma
Interventions
DRUG

Degarelix injection(s)

1 or 2 degarelix injection(s)

Trial Locations (1)

92140

Hôpital Antoine Béclère, Clamart

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT03947151 - Efficacy and Tolerance of an Ovarian Stimulation Protocol Combining Follicle Stimulating Hormone (FSH) and Degarelix Acetate in Female Candidates for Fertility Preservation Before Chemotherapy for Breast Cancer | Biotech Hunter | Biotech Hunter